Oxford Pharmascience scouts marketing partners for new pain meds

Oxford Pharmascience is hunting for a marketing partner for two new pain drugs. The U.K.-based pharma started contacting big drugmakers last fall, and has now hired consultants to pursue a deal on OXPzero Ibuprofen and OXPzero Naproxen. The new meds are reformulations of the two common pain relievers, tweaked to taste better and minimize digestive upset. Release